Aurora Cannabis Inc. Completes US$137.9 Million Cross-Border Bought Deal Offering

On January 26, 2021, Aurora Cannabis Inc. completed a bought deal public offering of units for total gross proceeds of US$137,940,000 pursuant to a prospectus supplement to the company’s short form base shelf prospectus dated October 28, 2020. The company sold 13,200,000 units at a price of US$10.45 per unit, including 1,200,000 units sold pursuant to the exercise in full of the underwriters’ over-allotment option. BMO Capital Markets and ATB Capital Markets acted as the bookrunners for the offering.

Aurora Cannabis is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company’s brand portfolio includes Aurora, Aurora Drift, San Rafael ‘71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD. Providing customers with innovative, high-quality cannabis products, Aurora’s brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched.

McMillan LLP acted as Canadian legal counsel to Aurora Cannabis with a team led by Cory Kent and Desmond Balakrishnan (Capital Markets & Securities) and included Marina Tran and Joni Liew (Capital Markets & Securities) and Andrew Stirling (Tax).